Bellars Harris Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bellars Harris Wealth Management's BMY Position: Q3 2026 in Review
Bellars Harris Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 6.2% in Q3 2026, selling an estimated $367K and leaving 87,774 shares worth $5.48M. The position accounts for 1.16% of the portfolio, ranked #42.
Bellars Harris Wealth Management first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Bellars Harris Wealth Management held 87,774 shares of Bristol-Myers Squibb worth $5.48M as of Q3 2026.
- Bellars Harris Wealth Management sold 5,804 Bristol-Myers Squibb shares in Q3 2026, an estimated $367K.
- Bristol-Myers Squibb made up 1.16% of Bellars Harris Wealth Management's portfolio in Q3 2026, its #42 holding.
- Bellars Harris Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Bellars Harris Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.